Volume 16 Number 2
June 2020

Volume 16 Number 2

This edition looks at valvular disease and heart failure with an examination of mitral valve repair in the MitraSwiss registry; a fuller understanding of the use of CT in patients undergoing TAVI; preprocedural planning for coronary re-access in candidates for TAVI-in-TAVI; a minifocus in Coronary interventions with a series on thin strut scaffolds; and, a look at interventional pharmacology with the SAFE-A trial comparing DAPT durations in patients  with atrial fibrillation on apixaban requiring coronary stenting.

Highlights from this issue

coronary
Coronary access after TAVR-in-TAVR
Coronary access after TAVR-in-TAVR
Tarantini G, Fabris T, Nai Fovino L
June 12, 2020
DOI: 10.4244/EIJ-D-19-01094
coronary
RENASCENT II: 9- and 24-month results of the APTITUDE BRS
RENASCENT II: 9- and 24-month results of the APTITUDE BRS
Chieffo A, Khawaja S, Latib A, Vesga B, Moncada M, Delgado J, Fonseca J, Testa L, Esposito G, Ferrone M, Cortese B, Maehara A, Granada J, Colombo A
June 12, 2020
DOI: 10.4244/EIJ-D-19-00600
coronary
SAFE-A study
SAFE-A study
Hoshi T, Sato A, Hiraya D, Watabe H, Takeyasu N, Nogami A, Ohigashi T, Gosho M, Ieda M, Aonuma K
June 12, 2020
DOI: 10.4244/EIJ-D-19-00920

Coronary interventions